The AEGIS-II trial, which enrolled 18,219 patients with AMI, tested whether CSL112 could reduce the incidence of MACEs, including MI, stroke, and cardiovascular death
The science, in other words, is solid
GLP-1/GIP medications (like Zepbound or Mounjaro) combine the effects of GLP-1 with another hormone, GIP, which further enhances appetite and cravings control along with improved metabolic health
For his part, Quebbemann is unequivocal that semaglutide shouldnt be permitted in elite competition
Additionally, this expanding patient population is very vulnerable to related comorbidities such as non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular diseases, which put a significant burden on healthcare systems
The key word is sustainable